• No results found

University of Groningen Modeling of MLL-AF9-rearranged pediatric leukemia Carretta, Marco

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Modeling of MLL-AF9-rearranged pediatric leukemia Carretta, Marco"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Modeling of MLL-AF9-rearranged pediatric leukemia Carretta, Marco

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Carretta, M. (2018). Modeling of MLL-AF9-rearranged pediatric leukemia: Identification of mechanisms and potential targets. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

!! ! ! ! ! ! ! ! ! !

Modeling of MLL-AF9-rearranged

pediatric leukemia

Identification of mechanisms and potential targets

(3)

!

The studies described in this thesis were financially supported by the grant: Marie Curie Euro Cancer Stem Cell Training Network FP7-PEOPLE-2010-ITN-264361. The publication of this thesis was financially supported by University of Groningen. Cover design: Oscar ‘Odd’ Diodoro, odd-house.com

Printed by: Ridderprint BV, www.ridderprint.nl ISBN 978-94-034-0440-0 (printed)

ISBN 978-94-034-0439-4 (e-book)

Copyright © 2018 by Marco Carretta. All rights reserved. No parts of this book may be reproduced or transmitted in any form or by any means without prior permission of the author.

(4)

Modeling of MLL-AF9-rearranged

pediatric leukemia

Identification of mechanisms and potential targets

PhD thesis

to obtain the degree of PhD at the University of Groningen

on the authority of the Rector Magnificus Prof. E. Sterken

and in accordance with

the decision by the College of Deans. This thesis will be defended in public on

Monday 5 February 2018 at 14.30 hours

by

Marco Carretta

born on 7 May 1985 in Mantova, Italië

(5)

! Supervisors Prof. J.J. Schuringa Prof. E. Vellenga Assessment Committee Prof. S. de Jong Prof. G. de Haan Prof. J. Jansen !

(6)
(7)

!

Paranymphs Vincenzo Terlizzi Bauke de Boer

(8)

TABLE OF CONTENTS

CHAPTER 1 9

General introduction and scope of the thesis

CHAPTER 2 45

Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model

Leukemia. 2016 Oct;30(10):2064-2073

CHAPTER 3 89

Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models

Exp Hematol. 2017 Jul;51:36-46.

CHAPTER 4 123

BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells

PLoS One. 2017 Dec 14;12(12):e0189102.

CHAPTER 5 159

The cell of maintenance in MLL-rearranged B-ALL is multipotent and retains myeloid potential while MLL-rearranged AML is maintained by myeloid restricted LSCs

Manuscript in preparation

CHAPTER 6 183

Summary, general discussion and future perspectives

CHAPTER 7 211

Nederlandse samenvatting Acknowledgements

Curriculum Vitae List of publications

(9)

Referenties

GERELATEERDE DOCUMENTEN

Upon transplantation of MLL-AF9-transduced CB CD34 + cells, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) developed in engineered scaffolds, in which

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright

%&' () *+ , -./ '(% !" !# !$ !% !& !' !( !) !* !"+ !"" !"# !"$ DX Relapse Alive UbiquitinC4 TP53C5 TcellC2 SMADC2 PKCC4 MEKC2 IAPC3 HypoxiaC5

Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing

A) Schematic representation of the different models injected with CB MLL-AF9 cells: IV injected NSG mice, ISC injected huBM-sc and ISC injected cytoBM-sc. Kaplan– Meier

Moreover, and once again as observed for the I- BET151 treated cells, none of the HOXA cluster of genes was affected by the ligand deprivation as confirmed also by qPCR for